Thursday, June 27, 2019 10:16:52 PM
SStartrade Tech, Inc. and Subsidiaries
CONSOLIDATED INCOME STATEMENT (Unaudited)
(Values in 000s | USD)
Period Ending Dec 31, 2018_____________
Total Revenue 188,467
Operating Expenses
Research and Development 31,604
Sales, General and Admin. 82,877
Non-Recurring Items 8,522
Other 60,952
Operating Expenses 183,955_____________
Gross Profit 4,512
Operating Income
Income From Continuing Operations
Add'l Income/Expense Items -
Interest Expense (2,473)
Earnings Before Tax 2,039
Income Tax (268)
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 1,771
Non-Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 1,771
Preferred Stock and Other Adjustments -_____________
Net Income Applicable to Common Shareholders 1,771
CONSOLIDATED BALANCE SHEETS
(Values in 000s | USD)
Period Ending Dec 31, 2018_________________
Assets
Current Assets
Cash and Cash Equivalents 33,863
Short Term Investments 8,547
Net Receivables 19,228
Inventory 3,812
Other Current Assets 9,174_________________
Total Current Assets 74,624
Long Term Investments - Property Plant and Equipment 19,197
Goodwill 7,044
Intangible Assets 48,870
Accumulated Amortization 1,877
Other Assets 6,718
Deferred Long Term Asset Charges 1,462_________________
Total Assets 159,792
Liabilities
Current Liabilities
Accounts Payable 39,844
Short Term and Current Long-Term Debt 68,362
Other Current Liabilities 11,281
Total Current Liabilities 119,487
Long Term Debt 18,054
Other Liabilities 19,864
Deferred Long Term Liability Charges 2,387
Minority Interest -
Negative Goodwill -________________
Total Liabilities 159,792
Stockholders' Equity
Misc. Stock Options Warrants -
Redeemable Preferred Stock - Preferred Stock -
Common Stock 99
Retained Earnings (25,352)
Treasury Stock -
Capital Surplus 25,352
Other Stockholder Equity -_________________
Total Stockholder Equity 0_________________
Net Tangible Assets 0
CONSOLIDATED CASH FLOW
(Values in 000s | USD)
Period Ending Dec 31, 2018__________________
Net Income Operating Activities
Depreciation - Adjustments to Net Income - Changes in Liabilities 13,812
Changes in Accounts Receivables (4,932)
Changes in Inventories 11,167
Changes in Other Operating Activities 6,688__________________
Total Cash Flow From Operating Activities 26,735 Investing Activities
Capital Expenditures (16,764)
Investments (8,823)
Other Cash Flows From Investing Activities -__________________
Total Cash Flow From Investing Activities (25,587)
Financing Activities
Dividends Paid - Sale/Purchase of Stock 0
Net Borrowings -
Other Cash Flows From Financing Activities -__________________
Total Cash Flow From Financing Activities 0
Balance of Cash and Cash Equivalents
at the beginning of the reporting period____ _____ 32,715_________________
Balance of Cash and Cash Equivalents
at the end of the reporting period_____________ ______ __ __ 33,863_________________
Balance of Cash Flows for the reporting period 1,148 Change in Cash and Cash Equivalents 1,148
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM